메뉴 건너뛰기




Volumn 60, Issue 6, 2006, Pages 655-659

Which thyroid-stimulating hormone level should be sought in hypothyroid patients under L-thyroxine replacement therapy?

Author keywords

CRP; D dimer; Fibrinogen; Homocysteine; Hypothyroidism; L thyroxine; TSH

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; CYANOCOBALAMIN; D DIMER; FIBRINOGEN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LEVOTHYROXINE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROTROPIN; THYROXINE; TRIACYLGLYCEROL;

EID: 33744524884     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-5031.2006.00822.x     Document Type: Article
Times cited : (12)

References (28)
  • 1
    • 0022085051 scopus 로고
    • Hypothyroidism and atherosclerotic heart disease: Pathogenesis, medical management, and the role of coronary artery bypass surgery
    • Becker C. Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev 1985; 6: 432-40.
    • (1985) Endocr Rev , vol.6 , pp. 432-440
    • Becker, C.1
  • 2
    • 0025340611 scopus 로고
    • Recognition and management of cardiovascular disease related to thyroid dysfunction
    • Ladenson PW. Recognition and management of cardiovascular disease related to thyroid dysfunction. Am J Med 1990; 88: 638-41.
    • (1990) Am J Med , vol.88 , pp. 638-641
    • Ladenson, P.W.1
  • 3
    • 0031911001 scopus 로고    scopus 로고
    • Thyroid hormone and cardiovascular disease
    • Gomberg-Maitland M, Frishman WH. Thyroid hormone and cardiovascular disease. Am Heart J 1998; 135: 187-96.
    • (1998) Am Heart J , vol.135 , pp. 187-196
    • Gomberg-Maitland, M.1    Frishman, W.H.2
  • 4
    • 0014249434 scopus 로고
    • Myxedema and coronary artery disease - A comparative autopsy study
    • Steinberg AD. Myxedema and coronary artery disease - a comparative autopsy study. Ann Intern Med 1968; 68: 338-44.
    • (1968) Ann Intern Med , vol.68 , pp. 338-344
    • Steinberg, A.D.1
  • 5
    • 0005339266 scopus 로고
    • The influence of thyroid hormones on cholesterol metabolism in experimental atherosclerosis in rabbits
    • Myasnikov AL, Myasnikov LA, Zaitzev VF. The influence of thyroid hormones on cholesterol metabolism in experimental atherosclerosis in rabbits. J Atheroscler Res 1963; 37: 295-300.
    • (1963) J Atheroscler Res , vol.37 , pp. 295-300
    • Myasnikov, A.L.1    Myasnikov, L.A.2    Zaitzev, V.F.3
  • 6
    • 0031005876 scopus 로고    scopus 로고
    • The effect of thyroid hormone therapy on angiographic coronary artery disease progression
    • Perk M, O'Neill BJ. The effect of thyroid hormone therapy on angiographic coronary artery disease progression. Can J Cardiol 1997; 13: 273-6.
    • (1997) Can J Cardiol , vol.13 , pp. 273-276
    • Perk, M.1    O'Neill, B.J.2
  • 7
    • 0031686061 scopus 로고    scopus 로고
    • Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism
    • Martinez-Triguero ML, Hernandez-Mijares A, Nguyen TT et al. Effect of thyroid hormone replacement on lipoprotein(a), lipids, and apolipoproteins in subjects with hypothyroidism. Mayo Clin Proc 1998; 73: 837-41.
    • (1998) Mayo Clin Proc , vol.73 , pp. 837-841
    • Martinez-Triguero, M.L.1    Hernandez-Mijares, A.2    Nguyen, T.T.3
  • 8
    • 0031034251 scopus 로고    scopus 로고
    • The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E
    • O'Brien T, Katz K, Hodge D et al. The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E. Clin Endocrinol (Oxf) 1997; 46: 17-20.
    • (1997) Clin Endocrinol (Oxf) , vol.46 , pp. 17-20
    • O'Brien, T.1    Katz, K.2    Hodge, D.3
  • 9
    • 0031934299 scopus 로고    scopus 로고
    • Plasma total homocysteine levels in hyperthyroid and hypothyroid patients
    • Nedrebo BG, Ericsson UB, Nygard O et al. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism 1998; 47: 89-93.
    • (1998) Metabolism , vol.47 , pp. 89-93
    • Nedrebo, B.G.1    Ericsson, U.B.2    Nygard, O.3
  • 10
    • 0034454116 scopus 로고    scopus 로고
    • Plasma total homocysteine levels during short-term iatrogenic hypothyroidism
    • Lien EA, Nedrebo BG, Varhaug JE et al. Plasma total homocysteine levels during short-term iatrogenic hypothyroidism. J Clin Endocrinol Metab 2000; 85: 1049-53.
    • (2000) J Clin Endocrinol Metab , vol.85 , pp. 1049-1053
    • Lien, E.A.1    Nedrebo, B.G.2    Varhaug, J.E.3
  • 11
    • 0034872102 scopus 로고    scopus 로고
    • Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment
    • Nedrebo BG, Nygard O, Ueland PM, Lien EA. Plasma total homocysteine in hyper- and hypothyroid patients before and during 12 months of treatment. Clin Chem 2001; 47: 1738-41.
    • (2001) Clin Chem , vol.47 , pp. 1738-1741
    • Nedrebo, B.G.1    Nygard, O.2    Ueland, P.M.3    Lien, E.A.4
  • 12
    • 0035093259 scopus 로고    scopus 로고
    • Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism
    • Chadarevian R, Bruckert E, Leenhardt L et al. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 2001; 86: 732-7.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 732-737
    • Chadarevian, R.1    Bruckert, E.2    Leenhardt, L.3
  • 13
    • 0038076459 scopus 로고    scopus 로고
    • What is the target TSH level in thyroid hormone replacement for primary hypothyroidism?
    • Zimmerman RS. What is the target TSH level in thyroid hormone replacement for primary hypothyroidism? Cleve Clin J Med 2003; 70: 329-30.
    • (2003) Cleve Clin J Med , vol.70 , pp. 329-330
    • Zimmerman, R.S.1
  • 14
    • 0034888086 scopus 로고    scopus 로고
    • Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients
    • McDermott MT, Haugen BR, Lezotte DC et al. Management practices among primary care physicians and thyroid specialists in the care of hypothyroid patients. Thyroid 2001; 11: 757-64.
    • (2001) Thyroid , vol.11 , pp. 757-764
    • McDermott, M.T.1    Haugen, B.R.2    Lezotte, D.C.3
  • 15
    • 0008313174 scopus 로고    scopus 로고
    • Laboratory Medicine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease, 2002 Washington, DC
    • National Academy of Clinical Biochemistry
    • Demers LM, Spencer CA. Laboratory Medicine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease, 2002 Washington, DC. In National Academy of Clinical Biochemistry (http://www.nacb.org).
    • Demers, L.M.1    Spencer, C.A.2
  • 16
    • 0036858505 scopus 로고    scopus 로고
    • American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism
    • American Association of Clinical Endocrinologists
    • American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002; 8: 457-69.
    • (2002) Endocr Pract , vol.8 , pp. 457-469
  • 17
    • 24344495292 scopus 로고    scopus 로고
    • The evidence for a narrower thyrotropin reference range is compelling
    • Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005; 90: 5483-8.
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 5483-5488
    • Wartofsky, L.1    Dickey, R.A.2
  • 18
    • 26944488996 scopus 로고    scopus 로고
    • Optimal thyrotropin level: Normal ranges and reference intervals are not equivalent
    • Dickey RA, Wartofsky L, Feld S. Optimal thyrotropin level: Normal ranges and reference intervals are not equivalent. Thyroid 2005; 15: 1035-9.
    • (2005) Thyroid , vol.15 , pp. 1035-1039
    • Dickey, R.A.1    Wartofsky, L.2    Feld, S.3
  • 20
    • 0025756673 scopus 로고
    • Hyperhomocysteinemia: An independent risk factor for vascular disease
    • Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-55.
    • (1991) N Engl J Med , vol.324 , pp. 1149-1155
    • Clarke, R.1    Daly, L.2    Robinson, K.3
  • 22
    • 0033533444 scopus 로고    scopus 로고
    • Normalization of hyperhomocysteinemia with 1-thyroxine in hypothyroidism
    • Hussein WI, Green R, Jacobsen DW, Faiman C. Normalization of hyperhomocysteinemia with 1-thyroxine in hypothyroidism. Ann Intern Med 1999; 131: 348-51.
    • (1999) Ann Intern Med , vol.131 , pp. 348-351
    • Hussein, W.I.1    Green, R.2    Jacobsen, D.W.3    Faiman, C.4
  • 23
    • 0034704893 scopus 로고    scopus 로고
    • C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
    • Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
    • (2000) N Engl J Med , vol.342 , pp. 836-843
    • Ridker, P.M.1    Hennekens, C.H.2    Buring, J.E.3    Rifai, N.4
  • 24
    • 0037300574 scopus 로고    scopus 로고
    • Elevated C-reactive protein and homocysteine values: Cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial
    • Christ-Crain M, Meier C, Guglielmetti M et al. Elevated C-reactive protein and homocysteine values: Cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 2003; 166: 379-86.
    • (2003) Atherosclerosis , vol.166 , pp. 379-386
    • Christ-Crain, M.1    Meier, C.2    Guglielmetti, M.3
  • 25
    • 0035106201 scopus 로고    scopus 로고
    • Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease
    • Muller B, Tsakiris DA, Roth CB et al. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur J Clin Invest 2001; 31: 131-7.
    • (2001) Eur J Clin Invest , vol.31 , pp. 131-137
    • Muller, B.1    Tsakiris, D.A.2    Roth, C.B.3
  • 26
    • 0031964035 scopus 로고    scopus 로고
    • Relationship between thyroid hormones and plasma D-dimer levels
    • Chadarevian R, Bruckert E, Ankri A et al. Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost 1998; 79: 99-103.
    • (1998) Thromb Haemost , vol.79 , pp. 99-103
    • Chadarevian, R.1    Bruckert, E.2    Ankri, A.3
  • 27
    • 0037347519 scopus 로고    scopus 로고
    • Blood coagulation and fibrinolytic activity in hypothyroidism
    • Erem C, Kavgaci H, Ersoz HO et al. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract 2003; 57: 78-81.
    • (2003) Int J Clin Pract , vol.57 , pp. 78-81
    • Erem, C.1    Kavgaci, H.2    Ersoz, H.O.3
  • 28
    • 0030875234 scopus 로고    scopus 로고
    • Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values
    • Lekakis J, Papamichael C, Alevizaki M et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 1997; 7: 411-4.
    • (1997) Thyroid , vol.7 , pp. 411-414
    • Lekakis, J.1    Papamichael, C.2    Alevizaki, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.